Cargando…
Trastuzumab Modified Barium Ferrite Magnetic Nanoparticles Labeled with Radium-223: A New Potential Radiobioconjugate for Alpha Radioimmunotherapy
Barium ferrite nanoparticles (BaFeNPs) were investigated as vehicles for (223)Ra radionuclide in targeted α-therapy. BaFe nanoparticles were labeled using a hydrothermal Ba(2+) cations replacement by (223)Ra with yield reaching 61.3 ± 1.8%. Radiolabeled nanoparticles were functionalized with 3-phosp...
Autores principales: | Gawęda, Weronika, Pruszyński, Marek, Cędrowska, Edyta, Rodak, Magdalena, Majkowska-Pilip, Agnieszka, Gaweł, Damian, Bruchertseifer, Frank, Morgenstern, Alfred, Bilewicz, Aleksander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589850/ https://www.ncbi.nlm.nih.gov/pubmed/33092037 http://dx.doi.org/10.3390/nano10102067 |
Ejemplares similares
-
Hybrid Radiobioconjugated Superparamagnetic Iron Oxide-Based Nanoparticles for Multimodal Cancer Therapy
por: Żuk, Michał, et al.
Publicado: (2021) -
Trastuzumab Conjugated Superparamagnetic Iron Oxide Nanoparticles Labeled with (225)Ac as a Perspective Tool for Combined α-Radioimmunotherapy and Magnetic Hyperthermia of HER2-Positive Breast Cancer
por: Cędrowska, Edyta, et al.
Publicado: (2020) -
Functionalized TiO(2) nanoparticles labelled with (225)Ac for targeted alpha radionuclide therapy
por: Cędrowska, Edyta, et al.
Publicado: (2018) -
Multimodal Radiobioconjugates of Magnetic Nanoparticles Labeled with (44)Sc and (47)Sc for Theranostic Application
por: Ünak, Perihan, et al.
Publicado: (2023) -
Trastuzumab-Modified Gold Nanoparticles Labeled with (211)At as a Prospective Tool for Local Treatment of HER2-Positive Breast Cancer
por: Dziawer, Łucja, et al.
Publicado: (2019)